JUVENILE PSORIATIC ARTHRITIS
Clinical trials for JUVENILE PSORIATIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE PSORIATIC ARTHRITIS trials appear
Sign up with your email to follow new studies for JUVENILE PSORIATIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with joint pain: risankizumab trial launches
Disease control Recruiting nowThis study tests a drug called risankizumab in children aged 2 to 17 with active juvenile psoriatic arthritis, a condition causing joint pain and swelling. About 40 participants will receive either risankizumab or the standard drug adalimumab for up to 2 years. The goal is to see…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
New study checks long-term safety of apremilast in kids with painful mouth sores or arthritis
Disease control Recruiting nowThis study looks at the long-term safety of the drug apremilast in children. It includes kids aged 2 and older with oral ulcers from Behçet's disease, or aged 5 and older with juvenile psoriatic arthritis. All participants must have completed a previous apremilast study. The main…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study checks safety of arthritis infusion for kids over 6 years
Disease control Recruiting nowThis study looks at how the drug secukinumab works in children aged 2 to 17 with juvenile psoriatic arthritis, a condition causing joint pain and skin patches. Researchers will measure drug levels in the blood and watch for side effects over up to 6 years. The goal is to understa…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New hope for kids with painful joints: daily pill aims to stop arthritis flares
Disease control Recruiting nowThis study tests a daily medication called deucravacitinib in 60 children aged 5 to 17 who have active juvenile psoriatic arthritis and haven't responded well to other treatments. The goal is to see if the drug can prevent arthritis flares and is safe for long-term use. Participa…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New hope for kids with arthritis? drug trial launches for young patients
Disease control Recruiting nowThis study tests a drug called bimekizumab in children aged 2 to 17 with active juvenile arthritis (enthesitis-related arthritis or juvenile psoriatic arthritis). The goal is to measure how the drug moves through the body and check for side effects. About 40 children will take pa…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:53 UTC